Cassandra Slader
Global Head of Managed Access Programs UCB
Cassandra Slader is Global Head of Managed Access Programs at UCB, where she leads the strategy and delivery of global access initiatives to enable patients to receive innovative therapies. With extensive experience across Medical Affairs and lifecycle strategy, she specialises in navigating complex healthcare systems, overcoming access barriers, and aligning cross-functional teams to deliver sustainable programmes. Having held senior leadership roles at Novartis across global and emerging markets, Cassandra brings deep expertise in integrating access into broader development and commercial strategy.
Seminars
Monday 19th October 2026
Workshop E – Operationalising Informed Consent & Physician Led Responsibilities Outside Clinical Trials
11:30 am
- Defining what “informed consent” means in treatment focused access programmes rather than research settings
- Clarifying where sponsor responsibility ends and physician responsibility begins in non GCP environments
- Managing variability in how consent is obtained, explained, documented, and revisited over time
- Establishing defensible guardrails to support physicians without crossing compliance or promotional boundaries
Wednesday 21st October 2026
Managing Early Access Requests for Excluded or High Risk Populations
8:30 am
- Managing access requests for populations typically excluded from trials or standard programmes (e.g. pregnancy)
- Translating incomplete or indirect evidence into defensible access decisions without creating research like risk
- Balancing ethical pressure to act against safety uncertainty and lower monitoring intensity in access programmes
- Establishing internal guardrails for exception based access that stand up to scrutiny
